Navigation Links
PharmMD Announces Denise Kehoe as Vice President of Business Development
Date:4/14/2008

NASHVILLE, Tenn., April 14 /PRNewswire/ -- Denise Kehoe has joined medication therapy management (MTM) company PharmMD as vice president of business development. In her new role, she will manage and oversee the expansion of the company's growing base of clients across the country.

Kehoe brings more than 15 years of clinical pharmacy, research and operations experience to PharmMD. She recently served as national strategic executive of managed care sales and contracting for Walgreens after holding positions with the company as a multi-site pharmacy manager, faculty practitioner, regional clinical manager and regional vice president. Prior to more than a decade with Walgreens, Kehoe was a relief pharmacist at the University of New Mexico Hospital in Albuquerque, N.M, and a research assistant for the Los Alamos National Laboratories Human Genome Project conducted at the University of New Mexico Health Sciences Center in Albuquerque.

PharmMD prevents medication-related health problems through the application of the best pharmacist and physician knowledge. The company works with employers and payers to help ensure that beneficiaries are receiving the most appropriate medications. Founded in 2006, PharmMD improves coordination and communication among physicians, pharmacists, payers and patients by analyzing pharmacy and medical claims information and clinical decision making. Because PharmMD focuses exclusively on MTM, the company is able to analyze both aggregate and patient-specific data to identify trends and conflicts to positively impact patient health and contain costs.

Kehoe is active in the leadership of several influential trade organizations. She participated on an American Pharmacists Association (APhA) strategic planning committee and is currently serving a two-year term as chair of specialized pharmacy for the APhA Academy of Pharmacy Practice Management. She received APhA fellowship honors in 2007. Kehoe is also currently serving on the Academy of Managed Care Pharmacy (AMCP) Community Pharmacy Outreach Task Force. She is involved with the National Association of Chain Drug Stores (NACDS) and recently spoke and moderated at the 2007 Medication Therapy Management Services in Community Pharmacy conference, which was jointly hosted by the NACDS and APhA. Kehoe also served as the president of the New Mexico Pharmacists Association where she was instrumental in implementing policies expanding the clinical practice role of pharmacists. Kehoe actively participates with collaborative healthcare initiatives promoting pharmacists as the medication experts.

"With her expert understanding of the clinical and operational delivery of pharmaceutical services and her passion for improving the health of individual patients, Denise will help develop and expand the customizable, personalized MTM services offered by PharmMD on a national level," said Bo Bartholomew, co- founder and chief executive officer of PharmMD.

Kehoe earned her bachelor's degree in pharmacy from the University of New Mexico in Albuquerque in 1992 and a master's of business administration from the University of Phoenix in Albuquerque in 1999. She later served as a member

of the dean's executive advisory board for the University of New Mexico College of Pharmacy.

"Medication error, misuse and abuse are pressing issues in today's healthcare environment, and the forward-thinking leaders at PharmMD are dedicated to the true purpose of medication therapy management - improving the quality of life for individual patients through improved medication usage," said Kehoe. "I am excited to join the company in working towards this worthwhile goal."

PharmMD is headquartered in Brentwood, Tenn. The company's web site can be accessed at http://www.pharmmd.com


'/>"/>
SOURCE PharmMD
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PharmMD Becomes an ASCP MTM Provider Partner
2. PharmMDs Brad Tice Named APhA Fellow
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Wells ... facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. , ... physicians and patients throughout the United States for high-quality human anti-aging and ...
(Date:1/19/2017)... ... January 19, 2017 , ... This month, the CEO and ... name of their drug rehab center in Delray Beach, Florida has been changed from ... only stars such as Philip Seymour Hoffman and Chris Farley are dying from heroin ...
(Date:1/19/2017)... , ... January 19, 2017 , ... WhoHaha , ... up with the American Heart Association (AHA) to produce a three-part video series that ... will debut as part of the launch of AHA’s Healthy For Good™ movement, which ...
(Date:1/19/2017)... ... January 19, 2017 , ... Cosmetic Town, an online ... procedures in order to make it easier for their readers to get the information ... they impact as well as the techniques used on those particular areas. , “We ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... and development solutions for drugs, biologics and consumer health products, today announced that ... with Gattefossé, the leader in innovative excipients and drug delivery solutions to health ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Calif. , Jan. 19, 2017  Abaxis, Inc. ... manufacturing point-of-care blood analysis instruments and consumables for the ... call to discuss its financial results for the third ... call will be at 4:15 p.m. ET on Thursday, ... for the third quarter fiscal year 2017 after the ...
(Date:1/19/2017)... , Jan. 19, 2017  Sensus Healthcare, ... device company specializing in the treatment of non-melanoma ... keloids, with superficial radiation therapy, today announced that ... year 2016 financial results on Thursday, February 2, 2017 ... will hold a conference call with the investment ...
(Date:1/19/2017)... , January 19, 2017 ... announced that the U.S. Food and Drug Administration (FDA) ... a New Drug Application (NDA) for SHP465, a long-acting, ... as a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). ... or around June 20, 2017, the designated Prescription Drug ...
Breaking Medicine Technology: